Antiviral Letermovir Purity 99% Letermovir Raw Material Powder Letermovir

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Letermovir
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Product Name: Letermovir
• Name: Letermovir Powder
• Appearance: White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Antiviral
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 917389-32-3
• Mf: C29h28f4n4o4
• MW: 572.561
• Density: 1.37+-0.1 g/cm3(Predicted)
• Boiling Point: 706.5+-70.0 C(Predicted)
• Refractive Index: 1.601
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 500kg/Month

Product Description

Antiviral Letermovir Purity 99% Letermovir Raw Material Powder Letermovir

 

Product Description

Product Details

Product Name	Letermovir
CAS No.	917389-32-3
MF	C29H28F4N4O4
MW	572.561
Appearance and shape	White powder

Letermovir (aic246, mk-8228) is a novel anti CMV compound, which targets the virus terminal enzyme complex and is also active for viruses resistant to DNA polymerase inhibitors.  Letermovir (aic246, mk-8228), a new drug for the treatment of adult patients who are seropositive for cytomegalovirus (CMV) after allogeneic hematopoietic stem cell transplantation (HSCT),
Letermovir is currently one of the Chemicalbook effective anti-HCMV (cytomegalovirus) reagents, its EC50 value in cells is about 5nM, and the selectivity index is more than 15000.

Application & Function

For use in prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant (HSCT).
Letermovir acts as an orally or i.v administered cytomegalovirus terminus complex inhibitor, antiviral agent, used in the treatment of CMV infection which is prevalent in those with immunocompromised systems.

Specification